Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Search results (312)

« Back to Publications

Our Future Health: a unique global resource for discovery and translational research.

Cook MB. et al, (2025), Nature medicine, 31, 728 - 730

"Target Trial Emulation" for Observational Studies - Potential and Pitfalls.

Hubbard RA. et al, (2024), The New England journal of medicine, 391, 1975 - 1977

Publisher Correction: Understanding the genetic complexity of puberty timing across the allele frequency spectrum.

Kentistou KA. et al, (2024), Nature genetics, 56, 1763 - 1764

Understanding the genetic complexity of puberty timing across the allele frequency spectrum.

Kentistou KA. et al, (2024), Nature genetics, 56, 1397 - 1411

Supplementary Table S5 from Assessing the Value of Incorporating a Polygenic Risk Score with Nongenetic Factors for Predicting Breast Cancer Diagnosis in the UK Biobank

Collister JA. et al, (2024)

Supplementary Table S7 from Assessing the Value of Incorporating a Polygenic Risk Score with Nongenetic Factors for Predicting Breast Cancer Diagnosis in the UK Biobank

Collister JA. et al, (2024)

Supplementary Table S4 from Assessing the Value of Incorporating a Polygenic Risk Score with Nongenetic Factors for Predicting Breast Cancer Diagnosis in the UK Biobank

Collister JA. et al, (2024)

Supplementary Table S9 from Assessing the Value of Incorporating a Polygenic Risk Score with Nongenetic Factors for Predicting Breast Cancer Diagnosis in the UK Biobank

Collister JA. et al, (2024)

Supplementary Table S8 from Assessing the Value of Incorporating a Polygenic Risk Score with Nongenetic Factors for Predicting Breast Cancer Diagnosis in the UK Biobank

Collister JA. et al, (2024)

Table 2 from Assessing the Value of Incorporating a Polygenic Risk Score with Nongenetic Factors for Predicting Breast Cancer Diagnosis in the UK Biobank

Collister JA. et al, (2024)

Table 1 from Assessing the Value of Incorporating a Polygenic Risk Score with Nongenetic Factors for Predicting Breast Cancer Diagnosis in the UK Biobank

Collister JA. et al, (2024)

Supplementary Table S6 from Assessing the Value of Incorporating a Polygenic Risk Score with Nongenetic Factors for Predicting Breast Cancer Diagnosis in the UK Biobank

Collister JA. et al, (2024)

Table 3 from Assessing the Value of Incorporating a Polygenic Risk Score with Nongenetic Factors for Predicting Breast Cancer Diagnosis in the UK Biobank

Collister JA. et al, (2024)

Supplementary Table S9 from Assessing the Value of Incorporating a Polygenic Risk Score with Nongenetic Factors for Predicting Breast Cancer Diagnosis in the UK Biobank

Collister JA. et al, (2024)

Table 1 from Assessing the Value of Incorporating a Polygenic Risk Score with Nongenetic Factors for Predicting Breast Cancer Diagnosis in the UK Biobank

Collister JA. et al, (2024)

Supplementary Table S8 from Assessing the Value of Incorporating a Polygenic Risk Score with Nongenetic Factors for Predicting Breast Cancer Diagnosis in the UK Biobank

Collister JA. et al, (2024)

Table 3 from Assessing the Value of Incorporating a Polygenic Risk Score with Nongenetic Factors for Predicting Breast Cancer Diagnosis in the UK Biobank

Collister JA. et al, (2024)

Supplementary Table S7 from Assessing the Value of Incorporating a Polygenic Risk Score with Nongenetic Factors for Predicting Breast Cancer Diagnosis in the UK Biobank

Collister JA. et al, (2024)

Table 2 from Assessing the Value of Incorporating a Polygenic Risk Score with Nongenetic Factors for Predicting Breast Cancer Diagnosis in the UK Biobank

Collister JA. et al, (2024)

Supplementary Table S6 from Assessing the Value of Incorporating a Polygenic Risk Score with Nongenetic Factors for Predicting Breast Cancer Diagnosis in the UK Biobank

Collister JA. et al, (2024)

Load More

1
2
3
4
5
6
7
...
»